By stretching the definition of European to include the United Kingdom, a topic about which everyone involved seems ambivalent, we can say that November opens with a set of three European longevity conferences, all within a few days of one another. The first is in London, running today, the second in Valencia, the third in…

There is a point in the life of a young biotech company at which one traditionally appoints an established figure from industry as the CEO. Running a company that is in the public eye due to clinical trials and heading in the direction of an IPO requires a whole different set of skills than were…

Today I’ll point out a view of the divide between theories of programmed aging and non-programmed aging, written from one of the more prominent programmed aging theorists in our community. I think it matters deeply as to whether we are guided by the theory that aging is caused by accumulated damage, or whether we are…

Mitochondria are the power plants of the cell, the descendants of ancient symbiotic bacteria. They retain a tiny remnant of the original bacterial genome, encoding thirteen genes essential to mitochondrial function. Most of the other genes moved to the cell nucleus over the course of evolutionary time, as mitochondria became ever more integrated as cellular…

Research into cellular senescence is at present one of the most exciting areas of the science of aging, as it is in this part of the scientific community that the first real, actual, legitimate rejuvenation therapies were discovered. These senolytic treatments, capable of selectively destroying senescent cells, are now in the process of verification in…

The Life Extension Advocacy Foundation volunteers hosted their first conference, Ending Age-Related Diseases 2018, in New York City a month ago. It was attended by a mix of advocates, scientists, entrepreneurs, and investors, all interested in seeing greater progress take place in the field of rejuvenation research. For those of us starting or running biotech…

I had promised a short update on progress at Repair Biotechnologies, the company that Bill Cherman and I founded earlier this year to help advance the state of therapies to treat aging, and here it is. We recently closed a seed round with a number of investors in our close-knit community, and are presently setting…

The Life Extension Advocacy Foundation (LEAF) volunteers have produced an excellent series of interviews of late, with many of the researchers of note involved in work aimed at better treating and understanding aging. João Pedro de Magalhães is one of the very long-standing members of the original small community of life extension advocates that emerged…

I would hope that by now Aubrey de Grey needs no introduction to the Fight Aging! readership. He is the co-founder of the Methuselah Foundation and SENS Research Foundation, originator of the SENS rejuvenation research programs, and tireless advocate for greater investment into the scientific foundations of near-future radical life extension. While history never depends…

Bill Cherman and I founded Repair Biotechnologies earlier this year in order to work on a few carefully selected approaches to human rejuvenation, following the SENS philosophy of damage repair. If one can be involved in the hands-on work, then why not be involved in addition to cheering from the sidelines? So here we are,…

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD